Univ of Louisville & Jewish Herita… - Form 990 Financial Data

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2003

Legal Domicile

Phone

5028521381

Tax Period

2018-07-01 to 2019-06-30

Univ of Louisville & Jewish Heritage Fund Cardiovascular Innovation Inst, founded in 2003, is a small nonprofit that reported $858K in total revenue in fiscal year 2018. Revenue surged 27% from the prior year, signaling strong growth momentum. Expenses of $760K left a modest 11% surplus.

Mission

The mission of the Cardiovascular Innovation Institute is to improve lives through world-class cardiovascular research, scientific discovery and new enterprise creation.

Program Service Accomplishments

Program 1

Expenses: $499,879 Revenue: $73,980

Research in the Cardiovascular Innovation Institute (CII) is focused on studying how the heart and cardiovascular system functions both normally and in the diseased state. The CII is doing research on the cellular and molecular level developing new knowledge on the underlining cause of cardiovascular disease. One of our researchers is studying small vessel disease in the hearts of women. This research is leading to new therapies for the treatment of women who have myocardial infarctions. Along with this research, work is being performed with adult stem cells turning the these cells into capillary to be vascularized ischemic myocardium. This work has been recognized by the National Institutes of Health and resulted in a R01 grant. Other researchers in the CII are working with C - RNA to detect both heart and lung disease and to better understand the mechanisms of action to help improve clinical treatments. There is also a very large lung research program at the Institute which is exploring mechanisms causing inflammatory lung disease using ex vivo lung perfusion techniques. One of the largest programs is the continual development of new ventricular assist devices and total artificial hearts. We have an outstanding large animal research lab and work in collaboration with multiple companies and the FDA perfecting the new devices for clinical testing. Researchers at the CII have published over 27 peer-reviewed articles during the year.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2018)

Revenue Breakdown

Contributions & Grants $711,692

Program Service Revenue $10,713

Investment Income $0

Other Revenue $135,139

TOTAL REVENUE $857,544

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $499,879

Other Expenses $759,801

TOTAL EXPENSES $759,801

Year-over-Year Comparison

	2018	2017	Change
Revenue	$857,544	$672,856	+0.3%
Expenses	$759,801	$833,750	-0.1%
Net Income	$97,743	$-160,894	-1.6%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
N/A	Chair (to 11/13/2018)	0.5	Officer Director	$0	$0	$0
N/A	Vice Chair	0.5	Officer Director	$0	$0	$0
N/A	Director	0.5	Director	$0	$0	$0
N/A	Director	0.5	Director	$0	$0	$0
N/A	Director	0.5	Director	$0	$0	$0
N/A	Director	0.5	Director	$0	$0	$0
N/A	Director	0.5	Director	$0	$0	$0
N/A	Director	0.5	Director	$0	$0	$0
N/A	Director	0.5	Director	$0	$0	$0
N/A	Director	0.5	Director	$0	$0	$0
N/A	Director	0.5	Director	$0	$0	$0
N/A	Medical and Exec. Director	0.5	Officer	$0	$0	$0
N/A	Scientific Director (to 12/31/18)	0.5	Officer	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2019	$857,544	$759,801	No data	$97,743
2018	$672,856	$833,750	$22,012	$-160,894

Univ of Louisville & Jewish Heritage Fund Cardiovascular Innovation Inst